Chad vs South-East Asia (WHO region): Hepatitis B surface antigen (HBsAg) prevalence
Chad
2.2%
in 2024
South-East Asia (WHO region)
0.2%
in 2024
Chad rank
11th
South-East Asia (WHO region) rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Chad
- South-East Asia (WHO region)
How they compare
Chad currently reports 2.2% against 0.2% in South-East Asia (WHO region), a difference of 2.0%.
That makes Chad's figure about 11.0 times South-East Asia (WHO region)'s.
Across all 10 years both countries report, Chad has been ahead every year.
Chad ranks 11th and South-East Asia (WHO region) ranks 8th of 194 countries.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.1% | 0.4% | 3.7% | Chad |
| 2020s | 3.0% | 0.3% | 2.7% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Chad or South-East Asia (WHO region)?
- Chad, at 2.2% against 0.2% in South-East Asia (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Chad and South-East Asia (WHO region)?
- 2.0%, with Chad ahead.
- How many years of comparable data are there for Chad and South-East Asia (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Chad and South-East Asia (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Chad ranks 11th and South-East Asia (WHO region) ranks 8th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.